Platform
Features
BioVeritas
Contact
Kyle Ross joined BioVeritas as VP of Process Development in February 2022.
Kyle Ross
VP, Process Development
Sign up to view 1 direct report
Get started
9 members
4 members
C4 Therapeutics
Oxford Nanopore Technologies
Zealand
Pathos
Keros Therapeutics